Keyphrases
Acute Myeloid Leukemia
100%
Venetoclax
28%
Leukemia
21%
Newly Diagnosed
21%
Np63
19%
MicroRNA
18%
Associated Genes
18%
TAp63
18%
Leukemia Patients
17%
Non-small Cell Lung Cancer (NSCLC)
13%
Chemotherapy
13%
Complete Remission
12%
Single Center
12%
Asparagine Synthetase
12%
Cutaneous Squamous Cell Carcinoma (cSCC)
12%
Sickle Cell Disease
12%
Proteome Array
12%
Reversed Phase
12%
Array Profiling
12%
Acute Promyelocytic Leukemia
12%
Therapeutic Strategies
11%
Overall Survival
10%
Cancer Progression
10%
Squamous Cell Carcinoma (SqCC)
9%
Hematopoietic Stem Cells
9%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
9%
Immune Checkpoint Blockade
9%
Tumor Protein p53 (TP53)
9%
CD8+ T Cells
9%
Intensive Chemotherapy
8%
Stem Cells
8%
Tumor
8%
In Cancer
8%
Relapsed or Refractory
7%
Murine Double Minute 2 (MDM2)
7%
MDM2-p53 Interaction
7%
P53 Activity
7%
Prognostic Role
7%
Myelodysplastic Syndrome
7%
7q Deletion
6%
Chromosome 7
6%
Acute Lymphoblastic Leukemia
6%
TP53 Alterations
6%
Phase II Trial
6%
DNA Damage
6%
Minimal Residual Disease
6%
T Cells
6%
Microenvironment
6%
Phase II Study
6%
Natural Killer Cells
6%
Medicine and Dentistry
Acute Myeloid Leukemia
87%
Malignant Neoplasm
28%
Venetoclax
24%
Diseases
22%
Neoplasm
20%
microRNA
18%
Leukemia
17%
Proteomics
17%
Overall Survival
16%
Immunity
13%
Stem Cell Therapy
13%
Protein P53
13%
Aspartate Ammonia Ligase
12%
Neonate
12%
Skin Carcinoma
12%
Prevalence
12%
Sickle-Cell Disease
12%
Neonatal Infant
10%
Arm
8%
T Cell
8%
Acute Lymphoblastic Leukemia
7%
Pediatrics Patient
7%
Offspring
7%
Pediatrics
7%
Lung Cancer
7%
Transcriptomics
7%
Immunotherapy
7%
Squamous Cell Carcinoma
7%
Allogeneic Stem Cell Transplantation
7%
Cancer Growth
6%
Precancerous Condition
6%
Stem Cell
6%
Oncologist
6%
Cellular Stress Response
6%
Combination Therapy
6%
Natural Killer Cell
6%
Newborn Screening
6%
Phlebotomy
6%
Cell Cycle
6%
Thalassemia Major
6%
Cell-Free DNA
6%
Mucositis
6%
Myeloid Sarcoma
6%
COVID-19
6%
Tertiary Care
6%
Enhancer Region
6%
Polycystic Ovarian Syndrome
6%
Milademetan
6%
Fertility Preservation
6%
Histone Deacetylase Inhibitor
6%